E Fund Management Co., Ltd. Caribou Biosciences, Inc. Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.82 - $8.26 $25,232 - $43,241	5,235 Added 25.72%	25,586 $131,000
Q4 2023 Feb 06, 2024	SELL	$3.58 - $6.25 $20,456 - $35,712	-5,714 Reduced 21.92%	20,351 $116,000
Q3 2023 Nov 13, 2023	BUY	$4.08 - $8.14 $106,345 - $212,169	26,065 New	26,065 $125,000
Q1 2023 May 11, 2023	BUY	$4.3 - $7.78 $9,391 - $16,991	2,184 Added 19.69%	13,274 $70,000
Q4 2022 Feb 14, 2023	BUY	$5.57 - $11.01 $61,771 - $122,100	11,090 New	11,090 $70,000

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $119M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.